The global Dental Bone Graft Substitute Market is experiencing robust growth, driven by a rising prevalence of dental issues and an increasing demand for cosmetic dental procedures. According to a new report by The Insight Partners, the market is projected to grow from USD 623.2 million in 2024 to USD 1.1 billion by 2031, at a CAGR of 7.21%.
Dental bone grafting is essential when bone loss in the jaw prevents successful placement of dental implants. Graft materials may be sourced from the patient (autograft), human or animal tissue banks (allograft/xenograft), or be synthetic (alloplast).
Oral diseases like dental caries, gum disease, and tooth loss affect billions globally. The WHO reports that 75% of people globally suffer from oral diseases, especially in middle-income countries. In the U.S., nearly half of adults over 30 have periodontal disease. These growing dental health concerns are fueling demand for bone grafting materials.
Cosmetic dentistry is another major driver. As more people seek procedures like dental implants and smile makeovers, bone grafting is often necessary to ensure structural support. Influences like social media, celebrity culture, and increasing awareness of dental aesthetics are accelerating market expansion.
Regionally, North America currently leads the market, followed by Europe. However, the Asia-Pacific region is expected to grow at the highest rate through 2031.
The report identifies key players including Dentsply Sirona Inc., Geistlich Pharma AG, ZimVie Inc., and Straumann Holding AG. New product launches and FDA approvals—like CMFlex from Desktop Metal—are contributing to innovation and growth.
As dental needs and cosmetic trends evolve, the market for dental bone graft substitutes is set to thrive, offering new opportunities for providers, manufacturers, and investors alike.
